Back to search

National and Kapodistrian University of Athens

Σχεδιασμός, ανάπτυξη και φαρμακολογική αξιολόγηση νέων παραγώγων ιντιρουμπίνης

Abstract

dc:description

Indigoids constitute a group of molecules that consist of indigo and its isomeric derivatives. Their chemical structure derives from the dimerization of two indolic compounds. They can be either isolated from natural sources, such as plants, mollusks, mammals or bacteries, or chemically synthesized. Indirubin derivatives (2’-3 connection of the two indolic rings), collectively referred to as indirubins, have shown a large number of pharmacological actions. The most important ones are anticancer, antiviral, antiparasitic and anti-inflammatory activity and neuroprotection. Derivatives of isoindigo (3’-3 connection of the two indolic rings) have also shown an important cytotoxic effect. Indirubins are potent pharmacological inhibitors of kinases. The most important and the most studied ones are cyclin-dependent kinases (CDKs) and glycogen synthase kinase-3 (GSK-3). Recently, it has been reported that certain indirubins inhibit Stat3 signaling. Some of them are also potent ligands of the dioxin receptor (AhR). The aforementioned molecular targets participate in the regulation of the cell cycle, but also in many other signaling pathways. Therefore, they are involved in many pathological situations where deregulation of these pathways is involved. Consequently, indirubins have been proven to be a valiable tool for the study of the cellular functions. At the same time, they constitute a very promising category of drug candidates. The biggest problem to be solved before their application in therapeutics is poor solubility and bioavailability. The assessement of all the information described before led to the principal aim of this phD thesis, which consisted of the synthesis of new derivatives bearing better pharmacological and pharmacokinetic properties. In summary, 113 new indirubin and isoindigo derivatives have been synthesized. Firstly, 3’ substitution of indirubin, 5-bromoindirubin and 7-bromoindirubin with hydrophilic groups was evaluated. It was demonstrated that this kind of substitution enhances in some cases the activity whether it concerns the inhibitory activity against kinases (derivatives of indirubin and 5-bromoindirubin) whether it concerns the cytotoxic activity of 7-bromoindirubin derivatives. Furthermore, 4’, 5’ and 6’ substituted derivatives of indirubin, 6-chloroindirubin, 6-bromoindirubin and 7-bromoindirubin were prepared. The first results concerning the inhibitory kinase activity of 6-substituted derivatives showed that 5’ substitution is the most suitable one. Their biological activities are still under investigation. In addition to the above, a whole new scaffold, 7-azaindirubin, and its derivatives have been synthesized. The interest of these compounds focuses in their cytotoxic activity (7-substituted indirubins don’t inhibit CDKs and GSK-3) which is not yet fully evaluated. A derivative of azaisoindigo was also synthesized and it showed no pharmacological interest. In order to explore the mechanism of action of 7-substituted indirubins and recognize their molecular targets, several compounds where substituted with long polyetheric aminic chains. The affinity chromatography of these derivatives is an undergoing procedure and results are not yet fully acquired. Finally, the metabolism in vitro of 6BIO and 7BIO was investigated and it was demonstrated that these are stable molecules which are almost uniquely metabolized in the corresponding glucuronides.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Κριτσανίδα, Μαρίνα
  • Kritsanida, Marina

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/18409

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Κριτσανίδα, Μαρίνα; Kritsanida, Marina. Σχεδιασμός, ανάπτυξη και φαρμακολογική αξιολόγηση νέων παραγώγων ιντιρουμπίνης. National and Kapodistrian University of Athens, 2007. http://hdl.handle.net/10442/hedi/18409